Novavax Stock Analysis

Novavax Stock Analysis Notes

About 57.0% of the company shares are owned by institutional investors. The company last dividend was issued on the 10th of May 2019. Novavax had 1:20 split on the 10th of May 2019. Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland. Novavax operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 1541 people. To find out more about Novavax contact Stanley Erck at 240 268 2000 or learn more at https://www.novavax.com.

Novavax Investment Alerts

Novavax Upcoming and Recent Events

Novavax Largest EPS Surprises

View All Earnings Estimates

Novavax Environmental, Social, and Governance (ESG) Scores

Novavax Stock Institutional Investors

Note, although Novavax's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Novavax Market Capitalization

The company currently falls under 'Mid-Cap' category with a current market capitalization of 1.13 B.

Novavax Profitablity

The company has Profit Margin (PM) of 0.38 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.77 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.77.

Management Efficiency

Novavax has return on total asset (ROA) of 0.1997 % which means that it generated a profit of $0.1997 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (8.982) %, meaning that it created substantial loss on money invested by shareholders. Novavax's management efficiency ratios could be used to measure how well Novavax manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.14 in 2025. Return On Capital Employed is likely to drop to -0.64 in 2025. At this time, Novavax's Total Assets are fairly stable compared to the past year. Non Current Assets Total is likely to rise to about 453 M in 2025, whereas Other Current Assets are likely to drop slightly above 57 M in 2025.

Technical Drivers

As of the 20th of July, Novavax secures the Downside Deviation of 3.91, mean deviation of 3.39, and Risk Adjusted Performance of 0.0552. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Novavax, as well as the relationship between them.

Novavax Price Movement Analysis

Novavax Insider Trading Activities

Novavax Outstanding Bonds

Novavax Predictive Daily Indicators

Novavax Corporate Filings

Novavax Forecast Models

Novavax's time-series forecasting models are one of many Novavax's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Novavax's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Novavax prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Novavax shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Novavax. By using and applying Novavax Stock analysis, traders can create a robust methodology for identifying Novavax entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Novavax analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Novavax analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Novavax stock analysis indicators help investors evaluate how Novavax stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Novavax shares will generate the highest return on investment. By understating and applying Novavax stock analysis, traders can identify Novavax position entry and exit signals to maximize returns.

When running Novavax's price analysis, check to measure Novavax's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Novavax is operating at the current time. Most of Novavax's value examination focuses on studying past and present price action to predict the probability of Novavax's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Novavax's price. Additionally, you may evaluate how the addition of Novavax to your portfolios can decrease your overall portfolio volatility.